Indications and uses
USES : Overactive proinflammatory immune activity, Psoriasis and Skin inflammation symptoms
USES : Overactive proinflammatory immune activity, Psoriasis and Skin inflammation symptoms
Take 15 minutes before meals. Adults and children 12 years and older 20 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow. Children between 12 years and 6 years of age 10 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow. Children under 6 years 5 drops twice a day in a glass of water.
INTERLEUKIN-11 4C Overactive proinflammatory immune activity, Psoriasis and Skin inflammation symptoms
USES: Overactive proinflammatory immune activity, Psoriasis and Skin inflammation symptoms
Stop use and ask doctor if symptoms worsen or persist more than 5 days
If pregnant or breast-feeding ask a doctor before use
Keep this and all medicines out of reach of children
Take 15 minutes before meals.
Adults and children 12 years and older 20 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow.
Children between 12 years and 6 years of age 10 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow.
Children under 6 years 5 drops twice a day in a glass of water.
Questions?: info@gunainc.com
Tel. (484) 223-3500
Inactive ingredient: Ethyl alcohol 30%.
Take 15 minutes before meals.
keep this and all medicines out of children
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17089-389-18 | 2020-03-13 | C162847 | 48780-1 | 9d75b9d0-1ca8-f424-e053-dadaa90a57ce | GUNA- IL 11 |
| 17089-389-18 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1ca8-f424-e053-dadaa90a57ce | GUNA- IL 11 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-389-18 | GUNA-IL 11 | 30 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 30 | 5 | |
| 17089-389-18 | GUNA-IL 11 | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| INTERLEUKIN-11 | ACTIVE INGREDIENT | O14Q7A13PT | 1 | |
| INTERLEUKIN-11 | ACTIVE MOIETY | O14Q7A13PT | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-389 | 17089-389-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| INTERLEUKIN-11 | O14Q7A13PT | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-IL 11 | INTERLEUKIN-11 | Guna spa | 2bceda80-56e9-40d9-9dfc-336deb6ec055 | 2022-11-15 | Warnings | 17089-389-18 17089-389 17089038918 ed81a1dd-c087-49a5-e053-2995a90aad04 2bceda80-56e9-40d9-9dfc-336deb6ec055 |
Adverse event summaries are temporarily unavailable. Other product information remains available.